DaVita HealthCare Partners Inc (DVA)
Return on equity (ROE)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 691,535 | 560,400 | 978,450 | 773,642 | 810,981 |
| Total stockholders’ equity | US$ in thousands | 1,056,100 | 712,326 | 755,508 | 1,383,570 | 2,133,410 |
| ROE | 65.48% | 78.67% | 129.51% | 55.92% | 38.01% |
December 31, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $691,535K ÷ $1,056,100K
= 65.48%
DaVita Inc's return on equity (ROE) witnessed fluctuations over the past five years. In 2023, the ROE stood at 65.48%, down from 78.67% in 2022, marking a decrease in the company's ability to generate profit from shareholders' equity. However, when compared to 2021 and 2020 where the ROE was 129.51% and 55.92% respectively, the 2023 ROE signifies a moderate performance. The trend shows an improvement from 2019 when the ROE was 38.01%. Overall, the company's ROE has shown variability, and it is essential to delve further into the financial and operational aspects to understand the reasons behind these shifts.
Peer comparison
Dec 31, 2023